{"schema_version":"1","generated_at":"2026-11-17T20:46:14.111Z","data_as_of":null,"url":"https://www.findmykol.com/kol/david-wallington","json_url":"https://www.findmykol.com/kol/david-wallington/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"david-wallington","name":"David Wallington","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Bronson Battle Creek Hospital","institution_url":"https://www.findmykol.com/institution/bronson-battle-creek-hospital","city":"Battle Creek","state":"MI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1598384380","orcid":"0000-0003-2669-8585","openalex":"A5045125822"},"summary":"David Wallington is an Oncology physician affiliated with Bronson Battle Creek Hospital. OpenAlex indexes 24 publications with 380 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":24,"cited_by_count":380,"h_index":8,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":17,"program_years":{"first":2021,"last":null},"rows_total":19,"shown":3,"withheld":16,"rows":[{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":60.59,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1598384380"},{"payer":"BeOne Medicines USA, Inc.","program_year":2025,"amount_usd":25.46,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1598384380"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":25.31,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1598384380"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1598384380","source":"payments"},"prescribing":{"data_year":2022,"areas_total":1,"areas_shown":1,"areas":[{"area":"Genitourinary & hormones","share_pct":100,"classes_total":1,"classes":[{"class":"alpha-Adrenergic Blocker","setting":"prescribed","share_pct":100,"drugs":[{"name":"Tamsulosin Hcl","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":24,"shown":5,"withheld":19,"matched_by":"OpenAlex author record","recent":[{"title":"Stepwise Craniospinal Irradiation: A Practical Approach to Urgent Palliative Focal Radiation Therapy as a “Bridge” to the Definitive Management of Acute Leptomeningeal Disease","year":2026,"journal":"Practical Radiation Oncology","source_url":"https://doi.org/10.1016/j.prro.2026.01.003","status":"verified"},{"title":"The Role of Radiotherapy in Lymphoma Patients Undergoing CAR T Therapy: Past, Present, and Future","year":2024,"journal":"Seminars in Radiation Oncology","source_url":"https://doi.org/10.1016/j.semradonc.2024.10.005","status":"verified"},{"title":"PO0205","year":2024,"journal":"Brachytherapy","source_url":"https://doi.org/10.1016/j.brachy.2024.08.140","status":"verified"},{"title":"Investigating the Relationship between the Dose to the Recto-Vaginal Reference Point and Vaginal Stenosis among Cervical Cancer Patients Treated at a North American Academic Institution","year":2023,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2023.06.1746","status":"verified"},{"title":"STING Agonists in Head and Neck Squamous Cell Carcinoma","year":2022,"journal":"The Cancer Journal","source_url":"https://doi.org/10.1097/ppo.0000000000000620","status":"verified"}],"source":"works"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":16,"publications":19}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}